MEDIFAST INC — Director's Dealing 2023

Mar 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-03-10

Reporting Person: SCHLACKMAN SCOTT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-10	Common Stock	M	2200	$27.68	Acquired	9480.092	Direct
2023-03-10	Common Stock	S	2200	$108.68	Disposed	7280.092	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-10	Stock Option (Right to Buy)	$27.68	M	2200	Disposed	2026-02-04	Common Stock (2200.0)	Direct

Footnotes

F1: The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.